Dietary potassium deficiency activates thiazide-sensitive sodium chloride cotransport along the distal nephron. This may explain, in part, the hypertension and cardiovascular mortality observed in individuals who consume a low potassium diet. Recent data suggest plasma potassium affects the distal nephron directly by influencing intracellular chloride, an inhibitor of the With no lysine kinase (WNK)-Ste20p-related proline-and alanine-rich kinase (SPAK) pathway. Since previous studies used extreme dietary manipulations, we sought to determine if the relationship between potassium and NCC is physiologically relevant and clarify the mechanisms involved. We report that modest changes in both dietary and plasma potassium affect the thiazide-sensitive sodiumchloride cotransporter, NCC, in vivo. Kinase assay studies showed that chloride inhibits WNK4 kinase activity at lower concentrations than it inhibits activity of WNK1 or WNK3. Also, chloride inhibited WNK4 within the range of distal cell chloride. Mutation of a previously identified WNK chloride-binding motif converted WNK4 effects on SPAK from inhibitory to stimulatory in mammalian cells. Disruption of this motif in WNKs 1, 3 and 4 had different effects on NCC, consistent with the three WNKs having different chloride sensitivities. Thus, potassium effects on NCC are graded within the physiological range, which explains how unique chloride-sensing properties of WNK4 enable kinase mediating effects of potassium on NCC in vivo.
Introduction
The antihypertensive effect of dietary potassium (K + ) supplementation has been recognized since the early part of the 20 th century. 1 Mechanistic explanations have been abundant, 2 generally focusing on extra-renal systems as sites of primary action, with few authors attributing a primary role for the nephron in sensing and responding to K + variation. Despite this, evidence for such a primary renal role is supported by a comprehensive model of longterm K + regulation reported thirty years ago. 3 Supporting this model, we recently reported on the molecular mechanism 4 by which the kidney senses and responds to changes in K + balance. Changes in plasma [K + ] affect the membrane potential of renal epithelial cells in the distal convoluted tubule (DCT), thereby altering their intracellular chloride concentration ([Cl -] i ). Such an effect might occur in multiple cell types in various organs, but two important facts cause these changes in the DCT to have great implications for K + and blood pressure homeostasis.
First, DCT cells are the only cell type in the kidney to express the thiazide-sensitive Na-Cl cotransporter (NCC). NCC and its molecular regulators, Ste20p-related proline-and alaninerich kinase (SPAK) and With no lysine (WNK) kinases, have been studied intensely since their dysregulation was implicated in the pathogenesis of Familial Hyperkalemic Hypertension (FHHt, also called pseudohypoaldosteronism type 2 or Gordon syndrome). 5 -7 without relevance to physiological balance. Given the narrow range in which plasma [K + ] is regulated, data obtained at K + concentrations less than 3mM and greater than 6mM should not be used to infer effects within a narrower range. in oocytes is near 50 mM. 22 Here, we test the hypotheses that physiologically relevant differences in dietary K + intake modulate both plasma [K + ] and NCC, and that unique Cl --sensing properties of WNK4, distinct from those of WNK1 and WNK3, make it able to transduce these physiological K + changes to NCC activity.
Results

Phosphorylated NCC and plasma [K + ] are correlated across a range of plasma [K + ] values
To determine if the inverse relationship between NCC and plasma [K + ] is continuous across a range of plasma [K + ], we examined pooled data from multiple mouse experiments in which dietary Na + and K + manipulation, aldosterone infusion, and combinations of these (described in Materials and Methods) were used (Fig 1) . Taken together, the results suggest that pNCC abundance is a linear function of plasma [K + ] within the investigated range. According to the model, from 4.5 mM to 3.0 mM, every 0.1 mM decrease in plasma [K + ] is associated with a 15% increase (relative to baseline) in normalized pNCC abundance.
Modest changes in dietary K + content affect plasma [K + ] and NCC in a graded fashion
Most studies investigating the relation between NCC abundance and K + , including ours, have employed severe dietary K + manipulations with 0 to 0.03% K + used for a low K + diet and 5% K + used for a high K + diet. 4 , 11 , 12 , 14 
22
, and the proposed importance of WNK4 for this effect, we determined the Cl -sensitivity of WNK4, and compared it to that of WNK1 and WNK3. In vitro kinase assays were performed using the various WNK kinase domains (WNK KD ) and SPAK as the physiologically-relevant kinase target. Our approach was similar to that reported by Piala and colleagues, except that they employed the generic substrate, myelin basic protein (MBP) for most of their studies. 8 We used E. coli to produce the three WNKs, a system that has been shown to yield phosphorylated and active WNKs. 8 Although Clinhibited all 3 WNKs, it inhibited WNK4 KD kinase activity at much lower concentrations than it did WNK1 KD or WNK3 KD (Fig 3a, b) . WNK4 KD was inhibited in the physiological range for DCT [Cl -] i 10 , 24 , 25 with the most potent effects between 0 and 40 mM (Fig 3e,f) .
WNK1 KD and WNK3 KD were inhibited at much higher levels, with WNK1 KD being inhibited between 60 and 150 mM and WNK3 KD inhibited between 100 and 150 mM (Fig  3c, d) . Note, that a fraction of the GST fusion SPAK protein was truncated on its C-terminus during preparation (Supplemental Fig 1) . Phosphorylation of both bands was quantified for these studies.
Mutating the WNK Cl-binding motif has different effects on WNK1, WNK3, and WNK4 in mammalian cells
In cultured cells and Xenopus oocytes, WNK4 has been observed commonly to inhibit SPAK (or oxidative stress response kinase, OxSR1; sometimes called OSR1) and NCC activity. This is in contrast to WNK1 and WNK3, which typically stimulate SPAK and NCC activity in the same model conditions. WNK4 inhibition of NCC activity in oocytes has been shown to require its ability to interact with other WNKs via its HQ domain. 18 Thus, BazuaValenti and colleagues suggested that, in oocytes, WNK4 is inactivated by ambient [Cl -] and thereby exerts a dominant-negative effect. 22 To test this hypothesis, we mutated the WNK4
Cl --sensing domain that is homologous to the WNK1 domain. 8 Although wild-type WNK4 decreased pSPAK in HEK cells, consistent with prior reports, WNK4 L322F L324F increased it (Fig 4a, Supplemental Fig 2) . The effects of WNK4 L322F L324F were kinase- dependent because mutation of the putative catalytic lysine (WNK4 L322F L324F K186M) returned pSPAK abundance to levels similar to that observed with WT WNK4 (Fig 4a) .
Mutating the Cl --sensing motif in the three different WNKs was also shown to have different effects on NCC phosphorylation. Consistent with the Cl-sensitivity reported by Piala et al. 8 , expression of the WNK1 mutant (WNK1 L369F L371F) increased pNCC by 140%, compared to expression of WT WNK1 (Fig 4b, e) . In contrast, expression of the WNK3 Cl --sensing mutant (WNK3 L295F L297F) had little effect on pNCC abundance compared to expression of WT WNK3 (Fig 4c, e) , supporting our observation (Fig 3) that WNK3 is the least sensitive to [Cl -]. Expression of WNK4 L322F L324F, on the other hand, increased pNCC abundance by 339% of that resulting from WT WNK4 expression (Fig 4d, e) . Thus, the effects of WNK4 chloride-sensing mutations were substantially larger than those of WNK1 and WNK3 (Fig 4e) .
Discussion
In with an IC 50 of 40 mM, but the authors concluded that this property does not mediate Clsensitivity in vivo, because it was shared with other kinases that do not mediate Clsignaling. Interestingly, the primary results were derived using a generic substrate, MBP, yet this group also tested the kinase activity of WNK1 against a physiological substrate, OxSR1 (also called OSR1). In this case, they observed an IC50 of 530 mM, a value outside the range of any mammalian cell. Because they found striking inhibition of WNK1 autophosphorylation by Cl -, in a concentration range compatible with physiological activity, they concluded that effects on autophosphorylation mediate effects of Cl -on kinase activity.
Our results were focused primarily on activity as the physiologically relevant parameter, so they do not provide direct information about autophosphorylation or transautophosphorylation. Several groups have documented that WNK kinases, as produced in E. coli, are phosphorylated and active. 8 , 35 , 36 Instead, our results point to clear differences in kinase Cl -sensitivity between WNK4, WNK1, and WNK3. Our experimental approach differed somewhat from that taken by Piala and colleagues. 8 First, an increase in [Cl -] in their experiments was also accompanied by a rise in tonicity, as they did not separate the two variables. We used an equimolar design in which either gluconate or Cl -was added to maintain tonicity. In this manner, our results support the conclusion of Uchida and colleagues that tonicity alone is not sensed by WNK kinases. 37 (Fig 4f) . As suggested by Figure 2 , however, the effects of plasma [K + ] on pNCC will be graded, forming a molecular rheostat. 26 The results indicate that quite modest changes in dietary K + intake affect plasma [K + ] and NCC activity. These effects are mediated largely by WNK4, as this kinase exhibits unique Cl --sensitive properties.
Methods Animals
Studies were approved by Oregon Health and Science University's Animal Care and Usage Committee (Protocol IS3286). Mice were 12-24 weeks BALB/c or a C57Bl/6.
Pooled data presented in Figure 1 are from five mouse experiments. For figure 1, plasma [K + ] and pNCC data were obtained from the following groups of animals: 1) 7-day aldosterone-infused (240 μg/kg/d, Alzet osmotic minipump model 1002) and sham-treated C57Bl/6 wild-type animals. 2) Same as 1), but BALB/c wild-type animals. 3) 7-day aldosterone-infused and sham-treated C57Bl/6 wild-type animals. Sham-treated mice were fed a normal K + diet (1%). Aldosterone-infused animals were fed either normal or high K + (5% K + ) diet. Normal and high K + diets were prepared by adding KCl to a K + -deficient diet (Harlan Laboratories K + -deficient diet; TD.88239) 4) 5 day normal (0.49% NaCl) and low NaCl diet-(Harlan Laboratories Na + -deficient (0.01-0.02% Na + ) diet; TD.90228) fed C57Bl/6 wild-type animals. NaCl was added to the Na + -deficient to 0.49% for normal NaCl diet. 5) 3 day normal and high K + diet-fed C57Bl/6 wild-type animals.
Data for figure 2 was obtained from a single mouse experiment using C57Bl/6 wild-type animals. Six groups of animals were each fed different amounts of K + for 10 days. KCl was added to the K + -deficient diet to achieve indicated dietary K + content for each group. Animals for Figure 2 were different from those for Figure 1 .
Antibodies
Custom antibodies against NCC 46 and pNCC-T53 47 have been reported before. Commercial antibodies used were directed against β-actin (Abcam), myc (Sigma), pSPAK-S373/ pOxSR1-S325 (Millipore), GST (Santa Cruz), and N-terminal SPAK (Santa Cruz). The C-terminal SPAK antibody was a generous gift of E. Delpire (Vanderbilt). The peptide used to block the N-terminal SPAK antibody was purchased from Santa Cruz.
Blood Analysis
Whole blood was collected via cardiac puncture at the completion of experiments. Plasma K + values were obtained by iSTAT just after collection by loading whole blood into a chem 8 cartridge (Abbot Point of Care, Inc).
Immunoblotting
At the completion of experiments, kidneys were harvested and snap-frozen in liquid nitrogen followed by transfer to a -80°C freezer. Kidneys were then homogenized on ice in chilled buffer containing protease and phosphatase inhibitors. Protein (50 μg) was separated on 4-12% Bis-Tris gel (Invitrogen). Densitometry was performed using ImageJ (http:// rsbweb.nih.gov/ij/).
Cell Culture
HEK 293 cells were cultured in DMEM with high glucose, sodium pyruvate, and LGlutamine (HyClone) supplemented with 10% fetal bovine serum and penicillin/ streptomycin. Cells were transfected with indicated constructs using Lipofectatime (Invitrogen), followed by harvesting and lysis 48 hours later. Total protein quantification and Western blots were then performed.
All WT WNK and NCC mammalian expression vectors have been previously reported. 18 Human WNKs 1, 3, and 4 cDNAs were subcloned into pMO-myc, which uses the SV40 promoter to drive expression. Mouse NCC was subcloned into pcDNA3.1. All point mutations were made using a QuikChange Lightning kit (Agilent Technologies).
In vitro Kinase Assays
GST fusion proteins were made by subcloning rat WNK1 (4-1473) 26 , human WNK3 (4-1260), 26 mouse WNK4 (4-1329), 48 and full-length mouse SPAK cDNAs into pGex6P-1.
Using a QuikChange Lightning kit (Agilent Technologies), the SPAK catalytic lysine (K104) was then mutated to an arginine, which has been shown to completely inhibit its kinase activity. 49 All kinase assays used this kinase dead GST-SPAK K104R construct.
Protein expression was induced in BL21 cells (Novagen).
Kinase assays were then performed by combining 0.25 ug of SPAK K104R with either 0.5μg of WNK1, 0.5μg of WNK3, or 5μg of WNK4 in kinase assay buffer (10mM HEPES, pH 8.0, 1mM benzamadine, 1mM DTT, and MgCl 2 /Mg gluconate) with 0.15mM cold ATP. MgCl 2 and Mg gluconate were added to vary the chloride concentration for a given experiment while maintaining all reactions at the same osmolality. Chloride was added in the amount indicated in figures. Reactions were incubated at 37°C for 45 minutes then stopped by adding SDS PAGE sample buffer and heating for 5 mins at 95°C. Samples were then loaded onto a 3-8% tris-acetate gel (Invitrogen) or a 4-12% Bis-tris gel (Bio-Rad) and Western blots were performed to quantify phospho-SPAK Ser383 and total SPAK (N-terminal). 
Statistics
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Pooled data from multiple animal experiments (see Methods for details) were correlated to determine the relationship between pNCC and plasma [K + ]. Phospho-NCC-T53 abundance was normalized to β-actin and each experiment had an internal control group (vehicle treatment or normal diet) whose pNCC average was set to 1. For each experiment, treatment groups were compared to their internal control group on normal diet. p<0.0001 for correlation. All mice used were wild-type. Colors indicate different experiments. Red: C57Bl/6 mice on normal (1%) or high K + (5%) diet, Blue: C57Bl/6 mice on normal (0.49%) or low NaCl (0.01-0.02%) diet, Black: C57Bl/6 mice that were either sham-treated or aldosterone-infused, Orange: Same as black, but BALB/c mice, Green: C57Bl/6 mice that were either sham-treated (on normal K + diet), aldosterone-infused (on normal K + diet), or aldosterone-infused (on high K + diet). 
